| __timestamp | Celldex Therapeutics, Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 104381000 | 31354781 |
| Thursday, January 1, 2015 | 100171000 | 43445817 |
| Friday, January 1, 2016 | 102726000 | 66489820 |
| Sunday, January 1, 2017 | 96171000 | 96886134 |
| Monday, January 1, 2018 | 66449000 | 153793000 |
| Tuesday, January 1, 2019 | 42672000 | 148369000 |
| Wednesday, January 1, 2020 | 42534000 | 151934000 |
| Friday, January 1, 2021 | 53311000 | 198532000 |
| Saturday, January 1, 2022 | 82258000 | 112128000 |
| Sunday, January 1, 2023 | 118011000 | 76192000 |
Cracking the code
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, TG Therapeutics, Inc. and Celldex Therapeutics, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, TG Therapeutics increased its R&D spending by approximately 143%, peaking in 2021 with a 198% rise compared to 2014. In contrast, Celldex Therapeutics experienced a more volatile R&D trajectory, with a notable dip in 2019, but rebounding to a 13% increase by 2023 compared to 2014. This divergence highlights TG Therapeutics' aggressive push towards innovation, while Celldex's strategy appears more cautious yet resilient. As these companies navigate the ever-evolving biotech landscape, their R&D investments will likely play a pivotal role in shaping their future breakthroughs.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Celldex Therapeutics, Inc.
Research and Development Investment: AstraZeneca PLC vs Celldex Therapeutics, Inc.
R&D Spending Showdown: BeiGene, Ltd. vs Celldex Therapeutics, Inc.
Research and Development Expenses Breakdown: BioMarin Pharmaceutical Inc. vs Celldex Therapeutics, Inc.
R&D Insights: How Exelixis, Inc. and Celldex Therapeutics, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
Halozyme Therapeutics, Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Blueprint Medicines Corporation vs Celldex Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Grifols, S.A. and Celldex Therapeutics, Inc.
R&D Spending Showdown: Corcept Therapeutics Incorporated vs Celldex Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Comparing Innovation Spending: Celldex Therapeutics, Inc. and Viridian Therapeutics, Inc.